Autoimmune Disease Diagnostics Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis

Coverage: Autoimmune Disease Diagnostics Market covers analysis By Type (Localized Autoimmune Disease Diagnostic, Systemic Autoimmune Disease Diagnostic); Product (Drugs, Therapeutic and Monitoring Equipment, Diagnostic Equipment); Technology (Bridge Therapy, Disease-modifying Antirheumatic Drugs (DMARD), Topical Therapy, Phototherapy, Helminthic Therapy, Recombinant Technology), and Geography (North America, Europe, Asia Pacific, and South and Central America)

  • Report Code : TIPRE00004904
  • Category : Biotechnology
  • Status : Upcoming
  • No. of Pages : 150
Buy Now

MARKET OVERVIEW

The immune system protects the body from various bacterial, viral infections and from other diseases. An autoimmune disorder is an abnormal immune response occurring in the body. Autoimmune diseases decrease the body's ability to fight the foreign particles resulting in attacking its own body's tissues. The autoimmune disease is more common in women than men. Crohn's disease, rheumatoid arthritis, inflammatory bowel disease, multiple sclerosis, systemic lupus erythematosus are some examples of autoimmune diseases. There are various tests commercially available at several healthcare centers to diagnose autoimmune diseases.

MARKET SCOPE

The "Global Autoimmune Disease Diagnostics Market Analysis to 2031" is a specialized and in-depth study of the food and beverages industry with a special focus on the global market trend analysis. The report aims to provide an overview of the autoimmune disease diagnostics market with detailed market segmentation by type, product, technology, and geography. The report provides key statistics on the market status of the leading autoimmune disease diagnostics market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

  •   Based on type, the global autoimmune disease diagnostics market is segmented into localized autoimmune disease diagnostic and systemic autoimmune disease diagnostic.
  •   On the basis of product, the market is segmented into drugs, therapeutic and monitoring equipment, and diagnostic equipment.
  •   Based on technology, the market is bifurcated into bridge therapy, disease-modifying antirheumatic drugs (DMARD), topical therapy, phototherapy, helminthic therapy, and recombinant technology.

MARKET DYNAMICS
Drivers:

  •   Growing public awareness about the various autoimmune diseases.
  •   Rising prevalence of autoimmune diseases
  •   Increasing the R&D activities on autoimmune diseases
  •   Technological innovation in the form of lab automation

Restraints:

  •   Lack of skilled healthcare practitioners
  •   High Cost and Reimbursement Issues

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The autoimmune disease diagnostics market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.

The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the marketduring the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the autoimmune disease diagnostics market in these regions.

IMPACT OF COVID-19 ON AUTOIMMUNE DISEASE DIAGNOSTICS MARKET

COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. Few companies have already announced possible delays in product deliveries and slump in future sales of their products. In addition to this, the global travel bans imposed by countries in Europe, Asia-Pacific, and North America are affecting the business collaborations and partnerships opportunities. Autoimmune disease diagnostics market is moderately affected due to COVID-19.

Autoimmune Disease Diagnostics Market Report Analysis

Autoimmune Disease Diagnostics Market
  • CAGR
    CAGR (2023 - 2031)
    XX%
  • Market Size 2023
    US$ XX Million
  • Market Size 2031
    US$ XX Million

Report Coverage

  • Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
  • Key future trends
  • Detailed PEST/Porter’s Five Forces and SWOT analysis
  • Industry landscape and competition analysis & recent developments
  • Detailed company profiles
  • Global and regional market analysis covering key market trends, major players, regulations, and recent market developments

Key Players

  • AstraZeneca
  • F. Hoffmann-La Roche
  • Novartis AG
  • Pfizer Inc.
  • Sanofi
  • Abbott Laboratories
  • Beckman Coulter, Inc.
  • Inova Diagnostics Inc.
  • Bio-Rad Laboratories Inc.

Regional Overview

Regional Overview
  • North America
  • Europe
  • Asia-Pacific
  • South and Central America
  • Middle East and Africa

Market Segmentation

Market Segment By Type
  • Localized Autoimmune Disease Diagnostic
  • Systemic Autoimmune Disease Diagnostic
Market Segment By Product
  • Drugs
  • Therapeutic and Monitoring Equipment
  • Diagnostic Equipment
Market Segment By Technology
  • Bridge Therapy
  • Disease-modifying Antirheumatic Drugs
  • Topical Therapy
  • Phototherapy
  • Helminthic Therapy
  • Recombinant Technology
MARKET PLAYERS


The report covers key developments in the autoimmune disease diagnostics market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from autoimmune disease diagnostics market are anticipated to lucrative growth opportunities in the future with the rising demand for autoimmune disease diagnostics in the global market.

The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the autoimmune disease diagnostics market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.

  •   AstraZeneca
  •   F. Hoffmann-La Roche
  •   Novartis AG
  •   Pfizer Inc.
  •   Sanofi
  •   Abbott Laboratories
  •   Beckman Coulter, Inc.
  •   Inova Diagnostics Inc.
  •   Bio-Rad Laboratories Inc.
  •   Hemagen Diagnostics Inc.

The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

Autoimmune Disease Diagnostics Market Report Scope

Report Attribute Details
Market size in 2023 US$ XX Million
Market Size by 2031 US$ XX Million
Global CAGR (2023 - 2031) XX%
Historical Data 2021-2022
Forecast period 2024-2031
Segments Covered By Type
  • Localized Autoimmune Disease Diagnostic
  • Systemic Autoimmune Disease Diagnostic
By Product
  • Drugs
  • Therapeutic and Monitoring Equipment
  • Diagnostic Equipment
By Technology
  • Bridge Therapy
  • Disease-modifying Antirheumatic Drugs
  • Topical Therapy
  • Phototherapy
  • Helminthic Therapy
  • Recombinant Technology
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • AstraZeneca
  • F. Hoffmann-La Roche
  • Novartis AG
  • Pfizer Inc.
  • Sanofi
  • Abbott Laboratories
  • Beckman Coulter, Inc.
  • Inova Diagnostics Inc.
  • Bio-Rad Laboratories Inc.
    • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
    • PEST and SWOT Analysis
    • Market Size Value / Volume - Global, Regional, Country
    • Industry and Competitive Landscape
    • Excel Dataset
    Report Coverage

    Report Coverage

    Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

    Segment Covered

    Segment Covered

    This text is related
    to segments covered.

    Regional Scope

    Regional Scope

    North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

    Country Scope

    Country Scope

    This text is related
    to country scope.

    Trends and growth analysis reports related to Biotechnology : READ MORE..   

    The List of Companies

    1. AstraZeneca
    2. F. Hoffmann-La Roche
    3. Novartis AG
    4. Pfizer Inc.
    5. Sanofi
    6. Abbott Laboratories
    7. Beckman Coulter, Inc.
    8. Inova Diagnostics Inc.
    9. Bio-Rad Laboratories Inc.
    10. Hemagen Diagnostics Inc.
    11. Thermo Fisher Scientific
    12. Siemens
    13. Danaher
    14. Grifols
    15. Trinity Biotech
    16. Werfen
    17. HYCOR Biomedical
    18. EUROIMMUN AG
    19. Oncimmune
    20. HTG Molecular Diagnostics